- Home
- / BlueSky Immunotherapies
BlueSky ImmunotherapiesBlueSky Immunotherapies
BlueSky Immunotherapies Summary
Company summary
- Overview
- BlueSky Immunotherapies (also known as BlueSky Vaccines) is a company focusing on developing next-generation immunotherapies against infectious diseases and cancer. It offers a proprietary platform for interferon-inducing viral vectors (delNS) that can activate antiviral and antitumoural responses.
- Type
- Private
- Status
- Active
- Founded
- 2017
- HQ
- Wien, AT | view all locations
- Cybersecurity rating
News
Footer menu
Products
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension